A phase II trial of TAS-102 in patients with colorectal cancer with ctDNA-defined minimal residual disease post-adjuvant therapy: Results from the MD Anderson INTERCEPT Program.

Abstract: This paper presents an improved variable-band hysteresis current controller for a two-level three-phase voltage source inverter (VSI). The controller takes the average voltages of the ...

Navitas announced a production-ready 12-kW PSU reference design that achieves 97.8% efficiency for hyperscale AI data centers ...

Abstract: Leakage current reduction is crucial for the transformerless photovoltaic inverters. The conventional three-phase current source H6 inverter suffers from the large leakage current, which ...